Search Results
Dec 18, 2025, 18:12 ET Halper Sadeh LLC Encourages UBFO, CWBC, RPTX Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-ubfo-cwbc-rptx-shareholders-to-contact-the-firm-to-discuss-their-rights-302646421.htmlSOURCE
More news about: Halper Sadeh LLP
Dec 17, 2025, 16:35 ET $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RPTX, FRGE, CSGS, FIZN
RPTX) related to its sale to XenoTherapeutics, Inc. Upon closing of the proposed transaction, it is estimated that each Repare shareholder will receive
More news about: Monteverde & Associates PC
Nov 28, 2025, 12:39 ET Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-ths-rptx-axta-shareholders-to-contact-the-firm-to-discuss-their-rights-302628064.htmlSOURCE
More news about: Halper Sadeh LLP
Nov 27, 2025, 23:13 ET HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMR
RPTX) related to its sale to XenoTherapeutics, Inc. Upon closing of the proposed transaction, it is estimated that each Repare shareholder will receive
More news about: Monteverde & Associates PC
Nov 17, 2025, 12:00 ET Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights
multimedia:https://www.prnewswire.com/news-releases/halper-sadeh-llc-encourages-rptx-see-cdtx-mrsn-shareholders-to-contact-the-firm-to-discuss-their-rights-302617222.html
More news about: Halper Sadeh LLP
Nov 14, 2025, 19:56 ET Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE, Nov. 14, 2025 /PRNewswire/ -- The Ademi Firm is investigating Repare (Nasdaq: RPTX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with XenoTherapeutics, Inc.
More news about: Ademi LLP